ArticleMolecular oncology2024

Combining VPS34 inhibitors with STING agonists enhances type I interferon signaling and anti-tumor efficacy.

Yasmin Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.